Patients with a history of diabetic retinopathy should be monitored appropriately, and any visual changes should be reported promptly
Purity: 99% HPLC | For research use only Categories: All Peptides, Weight Loss Tags: Anti-Diabetic Peptide, Appetite Suppression, C225H348N48O68, CAS 2023788-19-2, Dual Incretin Peptide, Fat Reduction, GIP Receptor Agonist, GLP-1, GLP-1 Analog, GLP-1/GIP Agonist, Glucose Control, Incretin Research, Insulin Sensitivity, Metabolic Disease Model, Metabolic Health, Obesity Research, Tirzepatide, Tirzepatide 10mg, Tirzepatide Research, Type 2 Diabetes Research, Weight Loss
Providers can also prescribe FDA-approved brand medications ( Zepbound, Mounjaro, Wegovy , and Ozempic ) when appropriate
If considering ginger supplements, discuss with your healthcare provider first, especially if you take blood thinners or other medications